🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Durvalumab and Tremelimumab in combination with first-line chemotherapy in ...
Status
Completed
Location
Research Site
Start Date
2016-04-28
Trial ID
NCT02658214
Treatments Being Tested
20010133 is an open-label, dose escalation study in pediatric patients with...
Status
Completed
Location
Arizona Cancer Center
Start Date
2006-08
Trial ID
NCT00460421
Treatments Being Tested
This study will examine the safety and effectiveness of an experimental dru...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
2003-02
Trial ID
NCT00054665
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Klinikum Augsburg
Start Date
2005-06
Trial ID
NCT00398554
Relapse remains a principle cause of treatment failure for patients with ag...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2010-08
Trial ID
NCT01181271
Treatments Being Tested
The objective of this protocol is to improve survival for adults with acute...
Status
Terminated
Location
UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center
Start Date
2014-01
Trial ID
NCT02043587
Treatments Being Tested
This study will be with pediatric patients who have refractory/recurrent so...
Status
Terminated
Location
New York Medical College
Start Date
2015-01
Trial ID
NCT02164097
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Veterans Affairs Medical Center - Palo Alto
Start Date
2006-09-26
Trial ID
NCT00274924
Randomized phase III trial to compare the effectiveness of combination chem...
Status
Completed
Location
Cancer and Leukemia Group B
Start Date
1998-01
Trial ID
NCT00003190
Treatments Being Tested
This phase II trial studies how well nivolumab works with the DA-REPOCH che...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2019-01-02
Trial ID
NCT03749018